The report will be delivered in 2-3 business days.

Genito-Urinary Drugs Market Global Briefing 2018

Starting Price : $ 1000.00 | Pages : 33 | Published : January 2018 | SKU CODE : 2769 | Format :

The genito-urinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, reno vascular diseases, benign prostate diseases, and other related diseases.

Genito-Urinary Drugs Global Market Size

The global genito-urinary drugs market was valued at around $60 billion in 2017. North America was the largest region in the genito-urinary drugs market in 2017, accounting for under 39% market share. The USA was the largest country in the market in 2017, accounting for above 30% market share.

Genito-Urinary Drugs Global Market Trend

The launch of combination products for the treatment of urinary tract infections is an emerging trend in the genito-urinary disorder drugs market. Competitors in the market are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genito-urinary disorders.

The major players in the global genito-urinary drugs market are Daiichi Sankyo Company, Limited Pfizer Inc., Bayer AG, Astellas Pharma Inc, and Allergan Plc.

The countries covered in the global genito-urinary drugs market are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

Genito-Urinary Drugs Global Market Segmentation

The genito-urinary drugs market is segmented into Hormonal Contraceptives, Drugs For Hormonal Replacement Therapy, Drugs For Infections And Others, Drugs for Benign Prostatic Hypertrophy, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs for Infertility, and Diuretics.
Hormonal Contraceptives segment includes organizations that manufacture medicines that act on the endocrine system and prevent pregnancy.
Drugs For Hormonal Replacement Therapy segment includes organizations that manufacture drugs that are used for the treatment used to relieve the symptoms of menopause.
Drugs For Infections And Others segment includes drugs for urinary tract infections, chlamydial infections, pyelonephritis, cystitis, leptospirosis, ulceration of the vulva, vaginitis and others.
Drugs for Benign Prostatic Hypertrophy - benign prostatic hypertrophy is the enlargement of the prostate gland that causes urination difficulty.
Drugs For Erectile Dysfunction - erectile dysfunction, also known as impotence, is a sexual dysfunction in which the ability to develop or maintain an erection of the penis during sexual activity is lost.
Drugs For Urinary Incontinence And Overactive Bladder - urinary incontinence and overactive bladder is the involuntary leakage of urine due to weakened or complete loss of control over the urinary sphincter.
Drugs for Infertility - infertility is defined as not being able to conceive due to reasons which may include inadequate hormone levels in men and women, ovulation problem in women.
Diuretics are medicines that promote increased production of urine.

New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Remdesivir Market Global Report 2020-30: COVID 19 Growth and Change
View Report
Biologics Market - By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), Trends, By Key Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2021
View Report

Call Us

+1 3156230293


+44 2071930708


+91 8897263534

(Asia & Others)